Abstract
In the past two decades, the treatment landscape for patients with metastatic renal cell carcinoma has significantly changed thanks to the approval of several targeted molecular therapies (VEGF and mTOR inhibitors) and recently immune-checkpoint inhibitors. The Italian Association of Medical Oncology (AIOM) Renal Cell Cancer (RCC) Guidelines Panel has developed clinical guidelines to provide evidence-based information and recommendations to oncologists, urologists and all professionals involved in the management of patients with renal cell cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 3-12 |
| Number of pages | 10 |
| Journal | Tumori |
| Volume | 105 |
| Issue number | 4_suppl |
| DOIs | |
| Publication status | Published - Jul 1 2019 |
Fingerprint
Keywords
- AIOM
- guidelines
- Italian
- recommendation
- renal cell cancer
ASJC Scopus subject areas
- Oncology
- Cancer Research
Cite this
Management of kidney cancer patients : 2018 guidelines of the Italian Medical Oncology Association (AIOM). / Giuseppa Vitale, Maria; Bracarda, Sergio; Cosmai, Laura; Crocetti, Emanuele; Di Lorenzo, Giuseppe; Lapini, Alberto; Mandressi, Alberto; Martorana, Giuseppe; Masini, Cristina; Montironi, Rodolfo; Ortega, Cinzia; Passalacqua, Rodolfo; Porta, Camillo; Procopio, Giuseppe; Sepe, Pierangela; Romano, Luigia; Luigi Pappagallo, Giovanni; Conti, Giario; Guida, Michele; Martignoni, Guido; Nolè, Franco; Pignata, Sandro; Gori, Stefania; Cartenì, Giacomo.
In: Tumori, Vol. 105, No. 4_suppl, 01.07.2019, p. 3-12.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Management of kidney cancer patients
T2 - 2018 guidelines of the Italian Medical Oncology Association (AIOM)
AU - Giuseppa Vitale, Maria
AU - Bracarda, Sergio
AU - Cosmai, Laura
AU - Crocetti, Emanuele
AU - Di Lorenzo, Giuseppe
AU - Lapini, Alberto
AU - Mandressi, Alberto
AU - Martorana, Giuseppe
AU - Masini, Cristina
AU - Montironi, Rodolfo
AU - Ortega, Cinzia
AU - Passalacqua, Rodolfo
AU - Porta, Camillo
AU - Procopio, Giuseppe
AU - Sepe, Pierangela
AU - Romano, Luigia
AU - Luigi Pappagallo, Giovanni
AU - Conti, Giario
AU - Guida, Michele
AU - Martignoni, Guido
AU - Nolè, Franco
AU - Pignata, Sandro
AU - Gori, Stefania
AU - Cartenì, Giacomo
PY - 2019/7/1
Y1 - 2019/7/1
N2 - In the past two decades, the treatment landscape for patients with metastatic renal cell carcinoma has significantly changed thanks to the approval of several targeted molecular therapies (VEGF and mTOR inhibitors) and recently immune-checkpoint inhibitors. The Italian Association of Medical Oncology (AIOM) Renal Cell Cancer (RCC) Guidelines Panel has developed clinical guidelines to provide evidence-based information and recommendations to oncologists, urologists and all professionals involved in the management of patients with renal cell cancer.
AB - In the past two decades, the treatment landscape for patients with metastatic renal cell carcinoma has significantly changed thanks to the approval of several targeted molecular therapies (VEGF and mTOR inhibitors) and recently immune-checkpoint inhibitors. The Italian Association of Medical Oncology (AIOM) Renal Cell Cancer (RCC) Guidelines Panel has developed clinical guidelines to provide evidence-based information and recommendations to oncologists, urologists and all professionals involved in the management of patients with renal cell cancer.
KW - AIOM
KW - guidelines
KW - Italian
KW - recommendation
KW - renal cell cancer
UR - http://www.scopus.com/inward/record.url?scp=85069269872&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069269872&partnerID=8YFLogxK
U2 - 10.1177/0300891619853392
DO - 10.1177/0300891619853392
M3 - Article
C2 - 31264522
AN - SCOPUS:85069269872
VL - 105
SP - 3
EP - 12
JO - Tumori
JF - Tumori
SN - 0300-8916
IS - 4_suppl
ER -